## BACKGROUND. Guidelines for follow-up of melanoma patients are not established. In 1987, a follow-up protocol was instituted at the Yale Melanoma Unit to improve upon the detection of disease recurrence in patients with American Joint Committee on Cancer Stage I-III cutaneous melanoma. The foll
A new American Joint Committee on Cancer staging system for cutaneous melanoma
โ Scribed by Charles M. Balch; Antonio C. Buzaid; Michael B. Atkins; Natale Cascinelli; Daniel G. Coit; Irvin D. Fleming; Alan Houghton Jr.; John M. Kirkwood; Martin F. Mihm; Donald L. Morton; Douglas Reintgen; Merrick I. Ross; Arthur Sober; Seng-Jaw Soong; John A. Thompson; John F. Thompson; Jeffrey E. Gershenwald; Kelly M. McMasters; for the AJCC Melanoma Staging Committee
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 78 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
O ver the past 2 decades, the principal clinical and pathologic fea- tures of melanoma that predict the risk of metastasis and survival rates have been delineated. The dominant independent prognostic factors involving melanoma patients treated throughout the world 1484
๐ SIMILAR VOLUMES
## BACKGROUND. The 1997 American Joint Committee on Cancer (AJCC) staging system condensed unilobular tumors into one entity and continues the use of both imaging and biopsy to alter classification status in T2 and T3 carcinomas. This study analyzes the biochemical freedom from disease recurrence
## BACKGROUND. This study was conducted to assess the effectiveness of the 1997 American Joint Committee on Cancer (AJCC) staging system to predict survival and local control of patients with maxillary sinus carcinoma and to identify significant factors for overall survival, local control, and dis
## BACKGROUND. Thickness is known to be an important survival prognosticator for cutaneous melanoma, but controversy exists as to whether Clark level of invasion retains prognostic significance once thickness has been accounted for. A recent proposal to eliminate Clark level from the staging system
I n patients with gastric carcinoma, anatomic extent is the strongest predictor of outcome. Following resection for cure (residual tumor classification: R0, no residual tumor), local and lymphatic spread are the most important prognostic factors. The classification of the local extent (T classifica